GlobeNewswire by notified

Implementation of new long-term share-based incentive programme

Share

The board of directors  of Svitzer Group A/S (the “Board of Directors”), CVR-no. 44791447, (“Svitzer Group” or the “Company”) has today decided to implement a new long-term share based incentive programme consisting of restricted share units (“RSUs”) for 2024 (the "LTI") and to implement an extraordinary share-based incentive programme in the form of one-off grants of RSUs related to completion of the demerger and separate listing of the Company ( “Extraordinary RSUs”) and grant a cash completion bonus to the members of the executive management and other eligible employees as also described in the prospectus published by Svitzer A/S on 22 March 2024.

Long-term share-based incentive programme for 2024
The LTI for 2024 is share-based and designed to incentivise long-term performance, commitment, and retention of the members of the executive management and other eligible employees, as well as to promote alignment of their interests with those of the shareholders.

Under the LTI for 2024, the Board of Directors have decided to grant RSUs, which entitle the participants, subject to vesting, to be allocated a number of shares in Svitzer Group, equivalent to the number of RSUs, which have vested but not lapsed. The CEO will be granted 85% of the annual fixed pay in the form of RSUs and the CFO will be granted 60% of the annual fixed pay in the form of RSUs. The implementation of the initial grants of RSUs under the LTI for 2024 is expected to take place in June 2024 and will be based on the volume weighted average share price (the “VWAP”) of the Company’s shares traded on Nasdaq Copenhagen in the first twenty (20) trading days from the first day of listing. 

RSUs under the LTI will be granted free of charge. Grants of RSUs do not depend on the achievement of specific goals. It is a requirement for participation in the LTI, and for any grant thereunder, that the participant in question is employed with the Company or the group on the date of the grant and that such employment is not under notice of termination.

RSUs granted under the LTI will have a vesting period of three (3) years calculated from 30 April 2024. The vesting of RSUs will be in accordance with the general terms and conditions of the LTI as determined by the Board of Directors, including usual good leaver and bad leaver provisions.

The aggregate value of the RSUs to be granted under the LTI for 2024 may amount to up to DKK 11.4 million.

Extraordinary RSU related to completion of the demerger and listing
The grant of Extraordinary RSUs is implemented to recognise the extraordinary effort and value creation by employees of the Company or the group in connection with the demerger and listing of Svitzer Group.

The Board of Directors has decided to provide one-off grants of Extraordinary RSUs to eligible employees of the group, which entitle the participants, subject to vesting, to be allocated a number of shares in Svitzer Group, equivalent to the number of RSUs, which have vested but not lapsed, subject to payment of par value of the shares. The implementation of the one-off grants of Extraordinary RSUs is expected to take place in June 2024 and will be based on the VWAP of the Company’s shares traded on Nasdaq Copenhagen in the first twenty (20) trading days from the first day of listing.

The granted Extraordinary RSUs will have a total vesting period of three (3) years calculated from 30 April 2024. Vesting of the Extraordinary RSUs is subject to the participant having complied with the general terms and conditions of the Extraordinary RSU Grant as determined by the Board of Directors. Vesting is not subject to the participant’s continued employment during the vesting period.

The aggregate value of Extraordinary RSUs may amount to up to DKK 5.72 million.

Cash completion bonus for members of the executive management
The members of the executive management and other eligible employees are eligible to receive an extraordinary completion bonus consisting of a cash bonus equal to up to 100% of their annual fixed base salary before the demerger. Each member of the executive management is required to use the extraordinary completion bonus (after tax) to acquire shares in the Company.

The aggregate value of the extraordinary completion bonus may amount to up to DKK 9.4 million.

About Svitzer

Svitzer is a leading, global towage and marine services provider. The core business is to assist large seaborne vessels in manoeuvring in and out of ports and terminals to berth and unberth. With more than 450 vessels, Svitzer’s services play a crucial role as part of critical port infrastructure. Svitzer was founded in 1833 and serves approximately 2,000 customers in more than 140 ports and 40 terminals across 37 countries. Read more on www.svitzer.com.

For further information, please contact:

Anders Crillesen
Head of Global Communications
E: anders.crillesen@svitzer.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

GXO Reports First Quarter 2024 Results7.5.2024 22:30:00 CEST | Press release

First quarter revenue of $2.5 billion, up 6% year over year; organic revenue growth1 of 1%Signed new business wins of approximately $250 million in annualized revenue in 1Q 2024; up 55% year over yearSales pipeline at 12-month high of $2.2 billionCompleted acquisition of Wincanton on April 29, 2024 GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2024. Malcolm Wilson, chief executive officer of GXO, said, “We delivered a strong start to 2024, reflecting our solid execution amid improving industry dynamics. The company grew revenue by 6% to $2.5 billion and delivered positive organic revenue growth, while gaining market share. We look forward to driving continued growth throughout 2024 and are on track to achieve our full-year outlook. “We’re seeing strengthening demand from global blue-chip customers to realize operational efficiencies today while planning fulfillment strategies to meet their future needs.

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update7.5.2024 22:30:00 CEST | Press release

Montrouge, France, May 7, 2024 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update VITESSE enrollment on track to screen last patient by Q3 2024Appointment of Robert Pietrusko, PharmD to Chief Regulatory OfficerQ1 2024 closes with a cash balance of $101.5 million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the first quarter 2024. The quarterly financial statements were approved by the Board of Directors on May 7, 2024. Recent Business Developments Clinical and Regulatory Update Enrollment for VITESSE, DBV’s Phase 3 pivotal study of the modified Viaskin Peanut patch in children ages 4 through 7 years with peanut allergy passed the halfway point for recruitment in Q1 and continues to be on track to screen the last patient by

SFL - Invitation to Presentation of Q1 2024 Results7.5.2024 22:19:00 CEST | Press release

SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the first quarter of 2024 on Tuesday, May 14, 2024. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, May 14, 2024, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at www.sflcorp.com. In order to listen to the conference call and presentation, you may do one of the following: A: Join Conference CallWebcast In Listen Only Mode: Visit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to "Webcast", or access directly via the webcast link below. The webcast with slideshow will be played live from this platform: SFL Corporation Ltd. Q1 2024 Webcast B: Join Conference Call AndParticipate in Live Q&AthroughZoom: Join through the Zoom link below to ask a question: SFL Q1 2024 Q&A Meeti

Oculis Publishes Invitation to the Annual General Meeting7.5.2024 22:05:00 CEST | Press release

Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST / 9:30 a.m. EDT. All information pertaining to the 2024 Annual General Meeting, including meeting materials, can be accessed on the Oculis website at https://investors.oculis.com/events-presentations. About Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior

Nokia Corporation: Repurchase of own shares on 07.05.20247.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 07 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 07.05.2024 Espoo, Finland – On 07 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL376,2023.48CEUX--BATE--AQEU--TQEX--Total376,2023.48 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye